631 related articles for article (PubMed ID: 16115766)
1. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2-yl]-2-oxoethyl] and N-[2-[5-(methylthio)thiophen-2-yl]-2-(oxyimino)ethyl]piperazinylquinolone derivatives.
Foroumadi A; Oboudiat M; Emami S; Karimollah A; Saghaee L; Moshafi MH; Shafiee A
Bioorg Med Chem; 2006 May; 14(10):3421-7. PubMed ID: 16427290
[TBL] [Abstract][Full Text] [Related]
5. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety.
Foroumadi A; Mohammadhosseini N; Emami S; Letafat B; Faramarzi MA; Samadi N; Shafiee A
Arch Pharm (Weinheim); 2007 Jan; 340(1):47-52. PubMed ID: 17206610
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
Foroumadi A; Firoozpour L; Emami S; Mansouri S; Ebrahimabadi AH; Asadipour A; Amini M; Saeid-Adeli N; Shafiee A
Arch Pharm Res; 2007 Feb; 30(2):138-45. PubMed ID: 17366732
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl)quinolones.
Wan ZL; Chai Y; Liu ML; Guo HY; Sun LY
Yao Xue Xue Bao; 2010 Jul; 45(7):860-8. PubMed ID: 20931783
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
Miyauchi R; Kawakami K; Ito M; Matsuhashi N; Ohki H; Inagaki H; Takahashi H; Takemura M
Bioorg Med Chem; 2009 Oct; 17(19):6879-89. PubMed ID: 19736016
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Inagaki H; Miyauchi S; Miyauchi RN; Kawato HC; Ohki H; Matsuhashi N; Kawakami K; Takahashi H; Takemura M
J Med Chem; 2003 Mar; 46(6):1005-15. PubMed ID: 12620077
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives.
Foroumadi A; Soltani F; Moshafi MH; Ashraf-Askari R
Farmaco; 2003 Oct; 58(10):1023-8. PubMed ID: 14505733
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of some novel N-substituted piperazinyl-quinolones.
Foroumadi A; Davood A; Mirzaei M; Emami S; Moshafi MH
Boll Chim Farm; 2001; 140(6):411-6. PubMed ID: 11822230
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antibacterial activity of quinolone/naphthyridone derivatives containing 3-alkoxyimino-4-(methyl)aminopiperidine scaffolds.
Lv K; Wu J; Wang J; Liu M; Wei Z; Cao J; Sun Y; Guo H
Bioorg Med Chem Lett; 2013 Mar; 23(6):1754-9. PubMed ID: 23402878
[TBL] [Abstract][Full Text] [Related]
17. A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group.
Kuramoto Y; Ohshita Y; Yoshida J; Yazaki A; Shiro M; Koike T
J Med Chem; 2003 May; 46(10):1905-17. PubMed ID: 12723953
[TBL] [Abstract][Full Text] [Related]
18. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antibacterial evaluation and QSAR studies of 7-[4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl] quinolone derivatives.
Kumar R; Kumar A; Jain S; Kaushik D
Eur J Med Chem; 2011 Sep; 46(9):3543-50. PubMed ID: 21689870
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives.
Akbas E; Berber I; Sener A; Hasanov B
Farmaco; 2005 Jan; 60(1):23-6. PubMed ID: 15652364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
